Stefan J.M. Kraemer, M.D., M.B.A. Email & Phone Number

Summit, Nj, Us

Summit, Nj, Us

Toronto, Ontario, Ca

Toronto, Ontario, Ca

Supporting start-ups and early stage companies in the LifeSciences in the development and commercialization of science and technology for the betterment of humankind.

Seattle, Washington, Us

The world’s only device for monitoring intracellular oxygen saturation, designed for early shock detection to help prevent multiorgan failure, with the potential to guide rapid initiation and tailored titration of targeted management. In December 2022, Opticyte received the BREAKTHROUGH DEVICE DESIGNATION from the FDA.

Galway, Connacht, Ie

Lifesciences - enabling and supporting innovation while excelling business growth

Franklin Lakes, New Jersey, Us

Appointed to lead Medical Affairs and Medical Safety for all BD Interventional businesses. Subsequently leading Medical Information Integration programme, focusing on development of a structured approach to MI in order to harness the value of information and data in a secure and reliable manner. Additionally, provided review and approval of MI content, supported the implementation of a new MI knowledge base and led training and supported scaled roll-out.

Franklin Lakes, New Jersey, Us

Appointed to lead Medical Affairs Pharmacovigilance. From 4.2018 to 5.2019 appointed to reestablish the Medical Affairs leadership for Pharmacovigilance for BD’s drug and drug & device combination products, a multi-billion $ segment of BD spread out across several business units. Lead the team that completed GAP analysis of existing and required PV reporting and governance, identified critical gaps in drug-device combination assessment required to be in compliance with EU-MDR, and immediately instituted Drug Safety Review Board for assessment of reported complaints and initiation of adequate actions.

Franklin Lakes, New Jersey, Us

In addition to responsibilities outlined in VP for MA role below, assigned responsibility for ensuring smooth transition of Medical Affairs during the Bard/Becton Dickinson merger.

Murray Hill, New Jersey, Us

Appointed to build a new Medical Affairs Department from scratch, bringing dedicated focus and expertise to the function. This covered Corporate, all Divisions, wholly-owned subsidiaries and International Business Centres including Bard China, Bard Japan, Australia and New Zealand, EMEA, Central and South America (4 MDs, 24 MA team members total, including 11 associates’ strong Medical Support Services team, providing multiple services to external and internal customers including, but not limited to, covering medical and scientific enquiries for the US and Canada 24/7/365, providing guidance for the correct use of all BARD devices, training (internal) customers on BARD devices and their correct use, and answering unsolicited requests for medical and scientific information.

WINGS – The Washington Medical Technology Angel Network facilitates seed and early stage investments for medical technology companies (therapeutic and diagnostic devices, healthcare IT, healthcare delivery models, and unregulated biotechnology development tools), growing the industry through increased deal flow in Washington State. We provide rigorous screening processes and subject matter expertise for members and start-ups, mentorship, and relationship building. We work actively with leading research institutions and other angel groups, enabling technologies that help patients.

Schramberg, Baden-Württemberg, De

REBMANN RESEARCH GmbH&Co KG is Germany’s leading provider of premium healthcare business information, delivering independent data, research and analysis that help business (banks, VCs, healthcare practitioners) and government clients make more informed strategic and operational decisions.Rebmann Research - Health Care Intelligence & Analysis™

Created novel device and procedure platform for endoluminal metabolic surgery to treat Type 2 Diabetes Mellitus, together with strong team of experienced, seasoned entrepreneurs and engineers.

Engaged in a range of projects and initiatives, including a new start-up to treat Type 2 Diabetes Mellitus (T2DM), devising prototypes including tissue-welding technology with a team of serial entrepreneurs and engineers, patent applications, fundraising, due diligence for start-ups and working with medical device companies, incubators and start-ups. Additionally, set up and co-led WINGS, the highly effective and innovative trade association serving the life sciences industry.

Redmond, Wa, Us

Founded and grew the business from concept through to fully operational, with a 140-strong team. Latterly, Chief Science & Technology Officer.

In 2001 Dr. Kraemer moved permanently to Seattle, WA, where he joined Scout Medical Technologies, an incubator for medical devices. In 2003 he and the Scout partners founded EsophyX Inc., now EndoGastric Solutions Inc.. Dr. Kraemer provided medical expertise to Scout, supported Scout portfolio companies with medical advice, and supported the team's due diligence on a number of projects, which were presented to the incubator.

B2B e-commerce exchange for the life science industry.

Munich, Bavaria, De

Board Certified Surgeon, Chirurgische Klinik Und Poliklinik Am Klinikum Rechts Der Isar

M.D., Medical School

Executive Mba, Business Administration And Management, General